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Abstract 
Phaeohyphomycosis (PHM) is a rare, deep fungal infection of the skin and subcutaneous 
tissues caused by dematiaceous fungi. In this report, we describe a case of PHM caused by 
Phaeoacremonium rubrigenum, which is generally known to infect woody plants. We 
detected the gray-blackish villi by biopsy culture material, and slide culture revealed the 
conidia arising from slightly tapering phialides. Furthermore, we differentiated these fungi as 
P. rubrigenum by Basic Local Alignment Search Tool (BLAST) algorithm. We performed 
surgical debridement of disseminated nodules and administered oral itraconazole for a 
duration of 4 weeks. One year after stopping itraconazole, there was no sign of relapsing 
subcutaneous nodules. To our knowledge, this is the third case report of PHM developing 
from skin infection by P. rubrigenum in human. 
 
Introduction 
Generally, dematiaceous fungal infections have been categorized into three groups: 
chromoblastomycosis (CBM), phaeohyphomycosis (PHM), and mycetomas, depending 
on the characteristic appearance of the pathogens in the infected tissue [1]. More than 
80% of these fungal infections are CBM, which usually affect the extremities and have 
the histological finding of sclerotic cell formation [1]. On the other hand, PHM is  
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histologically characterized by colored hyphae and spores, thereby distinguishing it 
from other dematiaceous fungal infections. 
PHM is a rare deep fungal infection of the skin and subcutaneous tissues caused by 
dematiaceous fungi. Most cases are caused by Exophiala jeanselmei, followed in 
frequency by Phialophora spp and Cladosporium spp. The majority of cases of PHM are 
thought to be in immunocompromised hosts [1]. There are only two cases of PHM 
caused by Phaeoacremonium rubrigenum in the English literature [2, 3]. In this report, 
we present a third case of PHM that developed in a patient with adult Still’s disease 
caused by P. rubrigenum. 
Case Report 
A 76-year-old woman consulted our outpatient clinic for a three-month history of multiple, 
proliferating subcutaneous nodules on her right leg. She had suffered from adult Still’s disease for 
three years and had been treated with oral prednisolone 15 mg/day for two years. On her first visit, 
physical examination revealed multiple subcutaneous abscesses, 10 to 30 mm in size, disseminated on 
the right leg, some of which were ulcerated (fig. 1). Laboratory data at the examination showed high 
serum levels of β-D glucan (94 pg/ml, normal range less than 20 pg/ml). Biopsy from nodules 
revealed dense infiltration of histiocytes, neutrophils and multinucleated giant cells. The 
dematiaceous fungi can be identified in the dermis and subcutaneous tissues (fig. 2a). In addition, 
Grocott staining of the biopsy specimen demonstrated numerous hyphae throughout the lesions (fig. 
2b). Cultures on Potato Dextrose Agar (PDA) detected the gray-blackish villi on the obverse side (fig. 
2c). Additionally, slide culture performed for one week at 25°C revealed conidia arising from slightly 
tapering phialides (fig. 2d). Furthermore, we extracted DNA from this cultured villi and submitted its 
sequence to the GenBank Basic Local Alignment Search Tool (BLAST) research and identified the 
infection of P. rubrigenum (fig. 3). From the above data, we diagnosed this patient as having PHM. We 
performed surgical debridement of the disseminated nodules and administered oral itraconazole 
(ITCZ) 400 mg once every week for 3 months. One year after stopping ITCZ, there was no sign of 
relapsing subcutaneous nodules. 
Discussion 
We describe a case of PHM forming multiple abscesses on the legs in a Japanese 
woman, in which we genetically detected P. rubrigenum from a skin abscess. Since this 
fungus commonly infects woody plants such as grapevines, to our knowledge, this is the 
third case report of P. rubrigenum affecting the human skin. 
Dematiaceous fungi, also called pigmented fungi, contain melanin-like pigment in the 
cell walls that arise from gray-blackish villi on the culture medium, and can cause a 
variety of infections in human known as PHM [1]. Taxonomically, PHM includes various 
deuteromycetes. Generally, dematiaceous fungi form muriform or sclerotic cells in 
healthy donors, but in immunosuppressed donors, these specific forms do not 
necessarily develop [1]. CBM, deriving from dematiaceous fungi, is known to mainly 
arise in healthy donors. In contrast, PHM mainly develops in immunocompromised 
hosts (e.g. malignant tumor, autoimmune disease). In the present case, since the patient 
had been administered oral steroid for adult Still’s disease for two years, her immune 
system might have been suppressed, with the result that the fungi formed typical 
hyphae.  
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At present, 29 species of Phaeoacremonium have been reported [4], three of which 
are associated with PHM (table 1) [2, 3, 5–16]. To our knowledge, it is extremely rare 
for P. rubrigenum to be detected in human organ cultures [2, 3]. P. rubrigenum typically 
appears as light purple-pink to brown colonies, with conidiophores that are mostly 
short and unbranched in slide cultures [4]. In humans infected with Phaeoacremonium, 
cutaneous or subcutaneous lesions are the most common, but there have been reported 
cases of central nervous system involvement [5], onychomycosis [6], endophthalmitis 
[7], endocarditis [8] and disseminated disease (fungemia) [9] (table 1). 
In the present case, the patient underwent surgical resection of the subcutaneous 
abscesses followed by administration of oral ITCZ 400 mg once every week for 3 
months. Previously, Ogawa et al. [19] reported the treatment for PHM by antifungal 
reagent (ITCZ, terbinafine, fluconazole or amphotericin B with ITCZ) after surgical 
resection. Interestingly, they selected ITCZ for 11/17 cases. In addition, the 
administration of ITCZ is permitted in Japan in two different ways: (1) 400 mg once 
every week for 3 months, and (2) 100~200 mg every day. It was recently reported that 
the recurrence rate of PHM under a conventional dose of ITCZ was about 66% (4/6) [2, 
3, 9, 10, 17]. In contrast, it was reported that there was no recurrence of PHM after the 
administration of 400 mg of ITCZ, though the report described only one case treated 
with ITCZ pulse therapy for PHM [18]. Therefore, in the present case, we selected high-
dose ITCZ therapy and there is no sign of local recurrence of PHM one year after the 
therapy. 
 
 
 
Table 1. Reported cases of human mycotic infections due to Phaeoacremonium species 
                        Case No.   Age of onset  Sex  Distribution of lesions  Species of fungi  Ref. 
                        01  61 years  female  left foot  Phaeoacremonium rubrigenum  02 
02  55 years  male  left ankle and foot  Phaeoacremonium rubrigenum  03 
03  24 years  male  brain  Phaeoacremonium parasiticum  05 
04  (middle-aged)  male  foot nail  Phaeoacremonium parasiticum  06 
05  (adult)  male  eye  Phaeoacremonium parasiticum  07 
06  45 years  male  endocardium  Phaeoacremonium parasiticum  08 
07  31 years  female  blood (fungemia)  Phaeoacremonium parasiticum  09 
08  40 years  male  left forearm, right buttock  Phaeoacremonium parasiticum  09 
09  26 years  female  left forearm  Phaeoacremonium parasiticum  10 
10  59 years  female  right knee  Phaeoacremonium parasiticum  11 
11  (adult)  male  forefinger  Phaeoacremonium parasiticum  12 
12  49 years  male  left foot  Phaeoacremonium parasiticum  13 
13  45 years  male  arm  Phaeoacremonium parasiticum  14 
14  14 months  male  blood (fungemia)  Phaeoacremonium inflatipes  15 
15  83 years  female  left knee  Phaeoacremonium inflatipes  16 
                        Present 
case 
76 years  female  right leg  Phaeoacremonium rubrigenum   
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Fig. 1. Multiple subcutaneous abscesses, 10 to 30 mm in size, on the right leg. 
 
 
 
Fig. 2. The dematiaceous fungi can be identified in the dermis and subcutaneous tissues (a). Grocott 
staining specimen revealed blackish hyphae throughout the nodules (b). The biopsy material was 
cultured on Potato Dextrose Agar (PDA) and the gray-blackish villi appeared on the obverse side (c). 
Slide culture for one week at 25°C. The conidia arising from slightly tapering phialides (d). 
Hematoxilin and eosin: original magnification ×200 (a), Grocott staining, original magnification ×200 
(b). 
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Fig. 3. Genetic analysis by Basic Local Alignment Search Tool (BLAST) research. 
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